• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FREE PSA; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FREE PSA; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS Back to Search Results
Catalog Number 08828610190
Medical Device Problem Codes Incorrect Measurement (1383); Non Reproducible Results (4029)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/01/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The serial number of the analyzer is (b)(6).The investigation is ongoing.
 
Event or Problem Description
We received an allegation about discrepant results for 1 patient's samples tested with elecsys total psa assay and elecsys free psa assay on a cobas 8000 e 801 module.This medwatch will apply to the elecsys free psa assay.Please refer to the medwatch with a1.Patient identifier: (b)(6) for information related to the elecsys total psa assay.The free psa (fpsa) value was greater than the total psa (tpsa) value.The tpsa results were 0.0294 ng/ml (accompanied by a data flag), 0.0229 ng/ml (accompanied by a data flag), and 0.563 ng/ml.The fpsa results were 0.584 ng/ml, 0.853 ng/ml, and 0.0413 ng/ml (accompanied by a data flag).
 
Additional Manufacturer Narrative
Medwatch fields a2, a3a, and b7 were updated.Correction to the results in medwatch field b5, as the last total psa and free psa results were switched.The questioned results should be: the tpsa results were 0.0294 ng/ml (accompanied by a data flag), 0.0229 ng/ml (accompanied by a data flag), and 0.0413 ng/ml (accompanied by a data flag).The fpsa results were 0.584 ng/ml, 0.583 ng/ml, and 0.563 ng/ml.
 
Additional Manufacturer Narrative
Qc and calibration were acceptable.No pre-analytical issue was identified.Sample material was requested for investigation; however, it was not available.Therefore, further investigation could not be performed.A general reagent problem can be excluded, as the qc was within range on the date of event.The investigation did not identify a product problem.The cause of the event could not be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FREE PSA
Common Device Name
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key23830048
Report Number1823260-2025-05175
Device Sequence Number5093419
Product Code MTG
UDI-Device Identifier07613336166628
UDI-Public07613336166628
Combination Product (Y/N)N
Initial Reporter CountryAR
PMA/510(K) Number
P000027/S037
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2026
Device Catalogue Number08828610190
Device Lot Number83220101
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/03/2025
Supplement Date Received by Manufacturer01/12/2026
02/27/2026
Initial Report FDA Received Date12/17/2025
Supplement Report FDA Received Date01/28/2026
03/24/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age69 YR
Patient SexMale
-
-